|
|
||||||||
B Signaling Pathway1






Departments of
*
Immunology and
Physiology and Pharmacology, Strathclyde Institute for Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom;
Department of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom; and
Wellcome Center for Molecular Parasitology, Anderson College, University of Glasgow, Glasgow, United Kingdom
Infection with lesion-derived Leishmania mexicana amastigotes inhibited LPS-induced IL-12 production by mouse bone marrow-derived macrophages. This effect was associated with expression of cysteine peptidase B (CPB) because amastigotes of CPB deletion mutants had limited ability to inhibit IL-12 production, whereas preincubation of cells with a CPB inhibitor, cathepsin inhibitor IV, was able to suppress the effect of wild-type amastigotes. Infection with wild-type amastigotes resulted in a time-dependent proteolytic degradation of I
B
and I
B
and the related protein NF-
B. This effect did not occur with amastigotes of CPB deletion mutants or wild-type promastigotes, which do not express detectable CPB. NF-
B DNA binding was also inhibited by amastigote infection, although nuclear translocation of cleaved fragments of p65 NF-
B was still observed. Cysteine peptidase inhibitors prevented I
B
, I
B
, and NF-
B degradation induced by amastigotes, and recombinant CPB2.8, an amastigote-specific isoenzyme of CPB, was shown to degrade GST-I
B
in vitro. LPS-mediated I
B
and I
B
degradation was not affected by these inhibitors, confirming that the site of degradation of I
B
, I
B
, and NF-
B by the amastigotes was not receptor-driven, proteosomal-mediated cleavage. Infection of bone marrow macrophages with amastigotes resulted in cleavage of JNK and ERK, but not p38 MAPK, whereas preincubation with a cysteine peptidase inhibitor prevented degradation of these proteins, but did not result in enhanced protein kinase activation. Collectively, our results suggest that the amastigote-specific cysteine peptidases of L. mexicana are central to the ability of the parasite to modulate signaling via NF-
B and consequently inhibit IL-12 production.
This article has been cited by other articles:
![]() |
K. Bryson, S. Besteiro, H. A. McGachy, G. H. Coombs, J. C. Mottram, and J. Alexander Overexpression of the Natural Inhibitor of Cysteine Peptidases in Leishmania mexicana Leads to Reduced Virulence and a Th1 Response Infect. Immun., July 1, 2009; 77(7): 2971 - 2978. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Mogensen Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses Clin. Microbiol. Rev., April 1, 2009; 22(2): 240 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Carvalho, E. J. Pearce, and P. Scott Functional Dichotomy of Dendritic Cells following Interaction with Leishmania braziliensis: Infected Cells Produce High Levels of TNF-{alpha}, whereas Bystander Dendritic Cells Are Activated to Promote T Cell Responses J. Immunol., November 1, 2008; 181(9): 6473 - 6480. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Soong Modulation of Dendritic Cell Function by Leishmania Parasites J. Immunol., April 1, 2008; 180(7): 4355 - 4360. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. MUKBEL, C. PATTEN JR., K. GIBSON, M. GHOSH, C. PETERSEN, and D. E. JONES MACROPHAGE KILLING OF LEISHMANIA AMAZONENSIS AMASTIGOTES REQUIRES BOTH NITRIC OXIDE AND SUPEROXIDE Am J Trop Med Hyg, April 1, 2007; 76(4): 669 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saito, M. Matsuura, and Y. Hirai Regulation of Lipopolysaccharide-Induced Interleukin-12 Production by Activation of Repressor Element GA-12 through Hyperactivation of the ERK Pathway. Clin. Vaccine Immunol., August 1, 2006; 13(8): 876 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pelletier and D. Girard Differential Effects of IL-15 and IL-21 in Myeloid (CD11b+) and Lymphoid (CD11b-) Bone Marrow Cells J. Immunol., July 1, 2006; 177(1): 100 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Olivier, D. J. Gregory, and G. Forget Subversion Mechanisms by Which Leishmania Parasites Can Escape the Host Immune Response: a Signaling Point of View Clin. Microbiol. Rev., April 1, 2005; 18(2): 293 - 305. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |